Clinical trial
Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or…
NCT00217516 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00217516 |
|---|---|
| Title | Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer |
| Official title | Supplementation of L-Selenomethionine in Patients With Prostate Cancer Prior to Brachytherapy. Selenium Brachytherapy Trial: Phase I/Pilot Study |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Other |
| Interventions | selenium, placebo |
| Enrollment | 18 |
| Start date | Mar 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 9, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: